Prevelance of Frailty and Its Associated Factors in Patients With Axial Spondyloarthritis
1 other identifier
observational
100
1 country
1
Brief Summary
Axial Spondyloarthritis is an inflammatory arthritis disease and its main symptoms are chronic pain and stiffness, causing structural damage to the spinal vertebrae. Axial Spondyloarthritis leads to physical disability and a decrease in the level of physical activity. Frailty is a syndrome characterized by decline in physiological reserve and loss of muscle strength. Frailty can lead to vulnerability of individuals to possible injuries and a decrease in independence, and ultimately an increase in mortality. Although frailty is associated with older adults, it has been reported that it can be detected in patients with cancer, diabetes and rheumatological diseases and it is not related with age. Frailty has been reported to be a reversible and a treatable condition. The aim of our study was to investigate the prevalence of frailty and the relationship between frailty and disease activity, physical functional level, quality of life and other associated factors in individuals with Axial Spondyloarthritis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2021
CompletedStudy Start
First participant enrolled
August 12, 2021
CompletedFirst Posted
Study publicly available on registry
August 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2022
CompletedJuly 5, 2022
June 1, 2022
6 months
August 12, 2021
June 29, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Fried Frailty Phenotype
The frailty level of the participants included in the study will be determined according to the frailty phenotype criteria of Fried et al. criteria for the diagnosis of frailty; Decreased grip strength, walking speed for 4 meters is less than the determined metrics ( for people who are 159 cm and shorter as \<6.12 sec or \>5.25 sec for those 159 cm and above), involuntary weight loss in the last year (≥4.5 kg) or body mass index ≤18.5 kg/m2, low physical activity level, and increased fatigue level reported by the participant. Individuals meeting 3 or more of these criteria are defined as "frail", individuals meeting 1 or 2 criteria are defined as "pre-fragile (pre-fragile) and individuals who do not meet any criteria are defined as "normal or robust".
1 day
Kihon Checklist
Frailty status will determined according to the Turkish version of the Kihon Checklist (KCL) which consists of 25 questions for yes (1) or no (0) answers. KCL includes seven categories as; physical function (5 items), mood (5 items), instrumental activities of daily life (5 items), nutrition (2 items), oral function (3 items), memory (3 items) and socialization (2 items). Total KCL scores range from 0 to 25 and scores ≥8 indicate frailty, between 4 to 7 indicate pre-frailty and between 0 to 3 indicate robustness.
1 day
Short Physical Performance Battery(SPPB)
SPPB can be used to determine frailty status. It comprises 3 parameters: static balance, sit to stand test and walking speed. Scores above 9 indicates no frailty, between 7 to 9 indicates pre-frailty and below 7 indicates frailty status.
1 day
Secondary Outcomes (4)
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
1 day
Bath Ankylosing Spondylitis Functional Index (BASFI)
1 day
Depression and Anxiety
1 day
Ankylosing Spondylitis Quality of Life Scale
1 day
Other Outcomes (3)
Gait Speed
1 day
Grip Strength
1 day
Physical Activity Level
1 day
Eligibility Criteria
Patients diagnosed with Axial Spondyloarthritis in a tertiary research and training hospital
You may qualify if:
- Diagnosed with Axial Spondyloarthritis by an experienced rheumatologist.
- To be between the ages of 40-65
You may not qualify if:
- Severe comorbidities such as cancer and stroke
- Being diagnosed with newly defined or recurrent cancer,
- Not having enough cognitive skills to answer the questions,
- Having neurological problems such as stroke
- Having cognitive impariment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haydarpaşa Numune Research and Training Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 12, 2021
First Posted
August 18, 2021
Study Start
August 12, 2021
Primary Completion
February 10, 2022
Study Completion
February 10, 2022
Last Updated
July 5, 2022
Record last verified: 2022-06